INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
The sheriff in Johnson County says there's a problem with stray bullets hitting property and even in one case, a person. The guns are…
Police have taken a person of interest in for questioning after several signs were stolen from property in Henry County.
ALERT: Frost Advisory issued for central Indiana tonight through 8 am Saturday morning.
Two people were arrested and property was seized after a drug raid occurred on Indianapolis’ east side Friday morning.
Enterprise Rent-A-Car has submitted plans to build a rental car facility, including an office and car wash, on the roof of the Broad Ripple…